LES-SVC July Chapter Meeting: "Navigating the Evolving Landscape of Life Sciences Licensing: Trends, Challenges, and Opportunities"

LES-SVC July Chapter Meeting:

"Navigating the Evolving Landscape of Life Sciences Licensing: Trends, Challenges, and Opportunities"

July 15, 2025 (TBC)

Location: TBC--Silicon Valley

Summary:
This moderated panel unites experts from pharma/biotech, law, academia, and investment to dissect mid-2025's life sciences licensing landscape. They'll explore key trends, deal dynamics, the impact of AI and macroeconomic pressures, early-stage valuation challenges, and emerging opportunities, offering actionable advice for navigating this evolving field.

Key Takeaways:

• Valuation & Creative Deals: Early-stage valuation remains a hurdle, driving innovative risk-sharing and milestone-based deal structures.
• Strategic Pipeline Shifts: Pharma balances M&A with licensing amidst evolving deal terms and notable geographical trends (e.g., China).
• AI's Impact on Deals: AI is reshaping licensing, from deal structures to IP challenges, making an AI strategy crucial for partnerships and investment.
• Future Outlook: Experts predict future licensing shifts, spotlighting untapped opportunities and offering advice for successful deal-making.